These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37083685)

  • 21. Usefulness of administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using paraoxon.
    Petroianu GA; Nurulain SM; Shafiullah M; Hasan MY; Kuča K; Lorke DE
    J Appl Toxicol; 2013 Sep; 33(9):894-900. PubMed ID: 22611016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotoxicity evoked by organophosphates and available countermeasures.
    Pulkrabkova L; Svobodova B; Konecny J; Kobrlova T; Muckova L; Janousek J; Pejchal J; Korabecny J; Soukup O
    Arch Toxicol; 2023 Jan; 97(1):39-72. PubMed ID: 36335468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of false transmitters as treatments for nerve agent poisoning.
    Whitmore C; Lindsay CD; Bird M; Gore SJ; Rice H; Williams RL; Timperley CM; Green AC
    Toxicol Lett; 2020 Mar; 321():21-31. PubMed ID: 31830555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of ranitidine.
    Petroianu GA; Arafat K; Schmitt A; Hasan MY
    J Appl Toxicol; 2005; 25(1):60-7. PubMed ID: 15669026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structures of paraoxon-inhibited human acetylcholinesterase reveal perturbations of the acyl loop and the dimer interface.
    Franklin MC; Rudolph MJ; Ginter C; Cassidy MS; Cheung J
    Proteins; 2016 Sep; 84(9):1246-56. PubMed ID: 27191504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of oxidative stress in organophosphate and nerve agent toxicity.
    Pearson JN; Patel M
    Ann N Y Acad Sci; 2016 Aug; 1378(1):17-24. PubMed ID: 27371936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detoxification of Organophosphate Poisoning Using Nanoparticle Bioscavengers.
    Pang Z; Hu CM; Fang RH; Luk BT; Gao W; Wang F; Chuluun E; Angsantikul P; Thamphiwatana S; Lu W; Jiang X; Zhang L
    ACS Nano; 2015 Jun; 9(6):6450-8. PubMed ID: 26053868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel immunoassay with direct relevance to protection against organophosphate poisoning.
    Heldman E; Balan A; Horowitz O; Ben-Zion S; Torten M
    FEBS Lett; 1985 Jan; 180(2):243-8. PubMed ID: 3881280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and subacute organophosphate poisoning in the rat.
    De Bleecker J; Lison D; Van Den Abeele K; Willems J; De Reuck J
    Neurotoxicology; 1994; 15(2):341-8. PubMed ID: 7991223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of red blood cell acetylcholinesterase measurement in mechanically ventilated subjects after organophosphate poisoning.
    Moon J; Chun B
    Respir Care; 2014 Sep; 59(9):1360-8. PubMed ID: 24865421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Affinities of bispyridinium non-oxime compounds to [(3)H]epibatidine binding sites of Torpedo californica nicotinic acetylcholine receptors depend on linker length.
    Niessen KV; Seeger T; Tattersall JE; Timperley CM; Bird M; Green C; Thiermann H; Worek F
    Chem Biol Interact; 2013 Dec; 206(3):545-54. PubMed ID: 24157926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-Membrane-Cloaked Oil Nanosponges Enable Dual-Modal Detoxification.
    Chen Y; Zhang Y; Zhuang J; Lee JH; Wang L; Fang RH; Gao W; Zhang L
    ACS Nano; 2019 Jun; 13(6):7209-7215. PubMed ID: 31117372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro protection of red blood cell acetylcholinesterase by metoclopramide from inhibition by organophosphates (paraoxon and mipafox).
    Petroianu G; Arafat K; Kosanovic M; Saleh A; Camasamudram V; Hasan MY
    J Appl Toxicol; 2003; 23(6):447-51. PubMed ID: 14635269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of tiapride.
    Petroianu GA; Hasan MY; Arafat K; Nurulain SM; Schmitt A
    J Appl Toxicol; 2005; 25(6):562-7. PubMed ID: 16193528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel slow-binding reversible acetylcholinesterase inhibitors based on uracil moieties for possible treatment of myasthenia gravis and protection from organophosphate poisoning.
    Saifina LF; Abdalla M; Gubaidullina LM; Zueva IV; Eltayb WA; El-Arabey AA; Kharlamova AD; Lenina OA; Semenov VE; Petrov KA
    Eur J Med Chem; 2023 Jan; 246():114949. PubMed ID: 36462442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro pharmacological characterization of the bispyridinium non-oxime compound MB327 and its 2- and 3-regioisomers.
    Niessen KV; Seeger T; Rappenglück S; Wein T; Höfner G; Wanner KT; Thiermann H; Worek F
    Toxicol Lett; 2018 Sep; 293():190-197. PubMed ID: 29024789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress in acetylcholinesterase reactivators and in the treatment of organophosphorus intoxication: a patent review (2006-2016).
    Gorecki L; Korabecny J; Musilek K; Nepovimova E; Malinak D; Kucera T; Dolezal R; Jun D; Soukup O; Kuca K
    Expert Opin Ther Pat; 2017 Sep; 27(9):971-985. PubMed ID: 28569609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A single dose of the organophosphate triazophos induces fear extinction deficits accompanied by hippocampal acetylcholinesterase inhibition.
    Rodrigues JVF; Vidigal APP; Minassa VS; Batista TJ; de Lima RMS; Funck VR; Antero LS; Resstel LBM; Coitinho JB; Bertoglio LJ; Sampaio KN; Beijamini V
    Neurotoxicol Teratol; 2020; 82():106929. PubMed ID: 33031921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plant-derived human acetylcholinesterase-R provides protection from lethal organophosphate poisoning and its chronic aftermath.
    Evron T; Geyer BC; Cherni I; Muralidharan M; Kilbourne J; Fletcher SP; Soreq H; Mor TS
    FASEB J; 2007 Sep; 21(11):2961-9. PubMed ID: 17475919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of Tetrameric Recombinant Human Butyrylcholinesterase as a Biopharmaceutical for Amelioration of Symptoms of Acute Organophosphate Poisoning.
    Terekhov SS; Palikov VA; Palikova YA; Dyachenko IA; Shamborant OG; Smirnov IV; Masson P; Gabibov AG
    Bull Exp Biol Med; 2017 Aug; 163(4):430-435. PubMed ID: 28853097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.